Cite
HARVARD Citation
Daniele, B. et al. (2015). Impact of sorafenib dosing on outcome from the European patient subset of the GIDEON study. Future oncology. pp. 2553-2562. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Daniele, B. et al. (2015). Impact of sorafenib dosing on outcome from the European patient subset of the GIDEON study. Future oncology. pp. 2553-2562. [Online].